We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.31B
1-Year Est. Return 18.36%
This Fund
S&P 500
This Quarter Est. Return
-12.88%
1 Year Est. Return
+18.36%
3 Year Est. Return
+53.76%
5 Year Est. Return
+60.8%
10 Year Est. Return
+204.74%
AUM
$2.02B
AUM Growth
-$304M
Cap. Flow
+$2.82M
Cap. Flow %
0.14%
Top 10 Hldgs %
20.11%
Holding
2,882
New
60
Increased
662
Reduced
773
Closed
206
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACWV icon
426
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.35B
$655K 0.03%
6,850
-275
-4% -$27.2K
GBCI icon
427
Glacier Bancorp
GBCI
$6.63B
$651K 0.03%
13,507
WBA
428
DELISTED
Walgreens Boots Alliance
WBA
$648K 0.03%
16,805
+3,017
+22% +$130K
ZTS icon
429
Zoetis
ZTS
$31.9B
$648K 0.03%
3,721
+75
+2% +$13K
FEMB icon
430
First Trust Emerging Markets Local Currency Bond ETF
FEMB
$360M
$647K 0.03%
24,362
+104
+0.4% +$2.93K
VB icon
431
Vanguard Morningstar Small-Cap ETF
VB
$82.3B
$643K 0.03%
3,602
-88
-2% -$17K
BSX icon
432
Boston Scientific
BSX
$71.1B
$640K 0.03%
16,845
-830
-5% -$33.8K
XITK icon
433
State Street SPDR FactSet Innovative Technology ETF
XITK
$75.5M
$638K 0.03%
5,821
XSLV icon
434
Invesco S&P SmallCap Low Volatility ETF
XSLV
$250M
$636K 0.03%
14,066
-108
-0.8% -$4.96K
ABXB
435
Abacus Flexible Bond Leaders ETF
ABXB
$1.92M
$634K 0.03%
29,214
+219
+0.8% +$4.88K
SFNC icon
436
Simmons First National
SFNC
$3.48B
$630K 0.03%
29,426
SHV icon
437
iShares 0-1 Year Treasury Bond ETF
SHV
$20.6B
$630K 0.03%
5,727
+3,091
+117% +$341K
GALT icon
438
Galectin Therapeutics
GALT
$196M
$626K 0.03%
478,067
+3,300
+0.7% +$4.74K
HYT icon
439
BlackRock Corporate High Yield Fund
HYT
$1.37B
$625K 0.03%
65,029
+660
+1% +$6.65K
EMB icon
440
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
$624K 0.03%
7,253
-1,803
-20% -$163K
FAST icon
441
Fastenal
FAST
$57B
$623K 0.03%
25,082
-1,660
-6% -$44.7K
HALO icon
442
Halozyme
HALO
$9.87B
$618K 0.03%
13,900
-400
-3% -$17.3K
STIP icon
443
iShares 0-5 Year TIPS Bond ETF
STIP
$15.8B
$618K 0.03%
6,080
+2,199
+57% +$227K
GTO icon
444
Invesco Total Return Bond ETF
GTO
$2.44B
$616K 0.03%
12,699
-4,208
-25% -$210K
DXCM icon
445
DexCom
DXCM
$32.8B
$615K 0.03%
7,929
-191
-2% -$17.4K
IXN icon
446
iShares Global Tech ETF
IXN
$8.81B
$614K 0.03%
13,479
-349
-3% -$17.6K
ISRG icon
447
Intuitive Surgical
ISRG
$130B
$605K 0.03%
2,936
-30
-1% -$7.04K
CEF icon
448
Sprott Physical Gold and Silver Trust
CEF
$7.54B
$603K 0.03%
36,156
+820
+2% +$14.9K
SPLK
449
DELISTED
Splunk Inc
SPLK
$601K 0.03%
6,539
-1,726
-21% -$190K
VBK icon
450
Vanguard Morningstar Small-Cap Growth ETF
VBK
$24.1B
$600K 0.03%
3,010
-549
-15% -$119K

Similar funds

Geneos Wealth Management's Q2 2022 Portfolio in Review

As of Q2 2022, Geneos Wealth Management held 2,882 positions worth $2.02B, down 13% from $2.33B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneos Wealth Management's Q2 2022 filing shows 60 new, 662 increased, 773 reduced and 206 closed positions. Its largest new stake was iShares MSCI Germany ETF: 78,679 shares worth $1.81M. The largest sale was Uncommon Portfolio Design Core Equity ETF, an estimated $12.6M.

By sector, the portfolio is most concentrated in Technology at 8.8% of assets, down from 9.7% a quarter earlier, followed by Financials and Healthcare.

  • Geneos Wealth Management's largest Q2 2022 buy was iShares MSCI Germany ETF: 78,679 shares worth $1.81M.
  • Geneos Wealth Management added most to State Street SPDR S&P 500 ETF Trust in Q2 2022, an estimated $11.8M increase.
  • Geneos Wealth Management's biggest Q2 2022 reduction was Uncommon Portfolio Design Core Equity ETF, cutting an estimated $12.6M.
  • Geneos Wealth Management fully exited ProShares Ultra S&P500 in Q2 2022, selling an estimated $1.65M.
  • Geneos Wealth Management's ten largest holdings make up 20% of its $2.02B portfolio in Q2 2022.
  • Geneos Wealth Management opened 60 new positions and closed 206 in Q2 2022.
  • Geneos Wealth Management's portfolio value fell 13% quarter-over-quarter to $2.02B.

Based on Geneos Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.